{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-020007","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.388036+00:00","generated_at":"2026-06-01T23:14:43.901112+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sigyn Therapeutics files PCT patent for ImmunePrep platform to enhance antibody delivery for cancer treatment","bullets":["Filed PCT application US24/28579 on May 9, 2024 for 'DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES'.","Patent covers ImmunePrep platform aimed at improving delivery of immunotherapeutic antibodies for cancer.","Inventors listed: Chairman and CEO James A. Joyce and Annette M. Marleau."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-020007","json":"https://secwatch.observer/filing/0001493152-24-020007.json","markdown":"https://secwatch.observer/filing/0001493152-24-020007.md","text":"https://secwatch.observer/filing/0001493152-24-020007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224020007/0001493152-24-020007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224020007/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:14:43.901112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}